Gaois

Cóip statach de shonraí a easpórtáiltear ó IATE ó am go chéile atá sa chnuasach seo. Níor cheart glacadh leis gurb ionann i gcónaí an t-eolas a thugtar faoi iontráil anseo agus a bhfuil sa leagan reatha den iontráil ar IATE. Is féidir an leagan reatha sin a cheadú ach cliceáil ar an nasc atá ar thaobh na láimhe deise ag barr gach iontrála. Breis eolais »

1 toradh

  1. SOCIAL QUESTIONS|health|health policy · SOCIAL QUESTIONS|health|pharmaceutical industry|pharmaceutical product · EUROPEAN UNION|European Union law|EU act

    #689869

    IATE #3645305
    Gníomh um Tháirgí Íocshláinte Criticiúla Tagairt "Téarmeolaithe COM-GA; arna bhunú ar: Treoirlínte polaitiúla don chéad Choimisiún Eorpach eile 2024-2029, Ursula von der Leyen, Iarrthóir ar Uachtaránacht an Choimisiúin Eorpaigh, an 18 Iúil 2024"
    ga
    Sainmhíniú gníomh reachtach atá molta arb é is aidhm dó slándáil sholáthar na gcógas san Aontas a neartú Tagairt "Téarmeolaithe COM-GA; arna bhunú ar: Teachtaireacht ón gCoimisiún: Aghaidh a thabhairt ar ghanntanais cógas leighis san Aontas"
    Rechtsakt zu kritischen Arzneimitteln
    de
    Sainmhíniú geplanter Vorschlag für einen Rechtsakt, der das Ziel verfolgt, die Versorgungssicherheit der EU bei Medizinprodukten und Arzneimitteln zu verbessern Tagairt "COM-DE gestützt auf: Politische Leitlinien für die nächste Europäische Kommission 2024 - 2029, Ursula von der Leyen – Kandidatin für das Amt der Präsidentin der Europäischen Kommission, 18.7.2024 (19.7.2024)"
    Critical Medicines Act
    en
    Sainmhíniú proposed legal act seeking to strengthen the EU’s security of medicines supply Tagairt "Council PL, based on: Commission Communication: Addressing medicine shortages in the EU"
    Nóta A Critical Medicines Act, which should take the form of an EU regulation, would provide an overarching regulatory framework for the following: 1) a legislative framework setting out the process for choosing which APIs are to be reshored in Europe; 2) a financing mechanism to develop industrial infrastructure for producing APIs and finished medicines in Europe (R & D, investment in infrastructure and technology and operating costs during the financing period); 3) relevant EU guidelines on pricing in the European market for finished products, and on reimbursement so that APIs and finished medicines produced in Europe can be competitive.
    acte législatif sur les médicaments critiques | loi sur les médicaments critiques | législation sur les médicaments critiques
    fr
    Sainmhíniú acte législatif proposé en vue de renforcer les capacités européennes de production de médicaments critiques ainsi que la résilience et l'autonomie stratégique de l'UE dans ce domaine Tagairt "Conseil-FR, d'après Communication de la Commission - Remédier aux pénuries de médicaments dans l’UE"